Profile
VNRX DHR-PB TMO DHR IDXX A
Company Name VolitionRx Limited Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $78.30M $916.76B $155.57B $143.61B $43.64B $33.26B
Employees 0.09K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Cameron Reynolds MBA Rainer M. Blair Marc N. Casper Mr. Rainer M. Blair Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
VNRX DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
VNRX DHR-PB TMO DHR IDXX A
Last Close $0.7515 $1261.26 $427.76 $202.5 $542.71 $120.66
High 52 $0.92 $1261.26 $624.21 $280.76 $542.93 $152.6
Low 52 $0.42 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -18.32 % 0 % -31.47 % -27.87 % -0.04 % -20.93 %
Price vs. 52 Week Low 78.93 % 0 % 9.63 % 15.95 % 50.32 % 21.52 %
Total Return
VNRX DHR-PB TMO DHR IDXX A
1 Month Return 35.53 % 0 % 6.91 % 5.44 % 3.21 % 7.01 %
3 Month Return 34.77 % 0 % -8.99 % 2.32 % 32.08 % 10.02 %
6 Month Return 13.54 % 0 % -19.61 % -13.79 % 30.65 % -11.08 %
9 Month Return -1.09 % 0 % -28.82 % -25.14 % 12.24 % -16.53 %
YTD Return 25.25 % 0 % -17.77 % -11.78 % 31.27 % -10.18 %
1 Year Return 16.86 % 0 % -20.08 % -15.63 % 13.66 % -4.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VNRX DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.4 % 0.56 % - 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) -43.98 % 2.93 % 4.05 % 2.93 % 7.41 % 3.43 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 23.76 %
Profitability
VNRX DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 31.67 % 59.74 % 41.57 % 59.74 % 61.32 % 53.79 %
Return on Assets TTM -281.97 % 4.76 % 6.58 % 4.76 % 27.85 % 9.59 %
Return on Equity TTM 108.01 % 7.47 % 13.34 % 7.47 % 57.35 % 19.46 %
Return on Capital Employed TTM -7548.03 % 6.66 % 8.53 % 6.66 % 55.24 % 13.97 %
Net Income Per EBT TTM 99.23 % 83.59 % 92.18 % 83.59 % 79.59 % 85.05 %
EBT Per Ebit TTM 129.88 % 93.35 % 96.45 % 93.35 % 97.98 % 96.75 %
EBIT Per Revenue TTM -1424.72 % 20.26 % 17.08 % 20.26 % 29.19 % 21.38 %
Cash Flow To Debt Ratio TTM -1189.7 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Receivables Turnover TTM 6.97 6.79 5.07 6.79 6.51 4.85
Payables Turnover TTM 0.22 5.57 - 5.57 12.66 5.94
Inventory Turnover TTM - 3.79 4.8 3.79 3.84 3.1
Fixed Asset Turnover TTM 26.65 % 466.14 % 459.74 % 466.14 % 471.66 % 346.65 %
Asset Turnover TTM 15.36 % 30.11 % 43.31 % 30.11 % 122.35 % 54.52 %
Operating Cash Flow Per Share TTM -0.23 8.72 21.53 8.72 11.91 5.56
Free Cash Flow Per Share TTM -0.23 6.84 17.79 6.84 10.3 4.91
Cash Per Share TTM 2.69 % 278.24 % 1573.28 % 278.24 % 201.64 % 521.4 %
Operating Cash Flow Sales Ratio TTM -1669.97 % 26.23 % 18.97 % 26.23 % 24.63 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.18 % 78.46 % 82.61 % 78.46 % 86.51 % 88.33 %
Cash Flow Coverage Ratios TTM -1189.7 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Price To Free Cash Flows Ratio TTM -3.54 29.02 23.14 29.3 52.1 23.76
Price To Operating Cash Flows Ratio TTM -3.36 22.79 19.14 23.01 45.57 21.05
Price Cash Flow Ratio TTM -3.36 22.79 19.14 23.01 45.57 21.05
Income Statement (TTM)
VNRX DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio -5.57% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $-0.03B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -0.31 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
VNRX DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0.04B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $-0.03B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0.01B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
VNRX DHR-PB TMO DHR IDXX A
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.03B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 120.66
ACRS Aclaris Therapeutics, Inc. 1.45
ADVB Advanced Biomed Inc. Common Stock 0.7
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 4.9357
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.275
BIAF bioAffinity Technologies, Inc. 0.29
BIAFW bioAffinity Technologies, Inc. 0.125
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.4
BNR Burning Rock Biotech Limited 3.23
CDNA CareDx, Inc 19.49
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.7522
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 157.49
CSTL Castle Biosciences, Inc. 20.01
DGX Quest Diagnostics Incorporated 176.6
ETFs With Exposure to VNRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00003 135.77
VXF Vanguard Extended Market Index Fund 0.00039 195.67
IWC iShares Micro-Cap ETF 0.00282 131.5
STSB iShares Factors US Small Blend Style ETF 0.01 22.13
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00039 148.44
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000464909 105.23
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00039 148.45
VEMPX Vanguard Extended Market Index InstlPlus 0.00039 366.31
Unlock